199 results on '"McCarthy, William F."'
Search Results
2. The Impact of Hydroxyurea on Career and Employment of Patients With Sickle Cell Anemia
3. Hydroxyurea and Acute Painful Crises in Sickle Cell Anemia: Effects on Hospital Length of Stay and Opioid Utilization During Hospitalization, Outpatient Acute Care Contacts, and at Home
4. Climatic and geographic temporal patterns of pain in the Multicenter Study of Hydroxyurea
5. Supplement to: Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.
6. Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program follow-up study
7. Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
8. Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
9. WITHDRAWN: Managing Environmental Compliance: A Study of Expansion, Replacement and Integrity Projects
10. Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO angiographic experience
11. The Association Between Hydroxyurea Treatment and Pain Intensity, Analgesic Use, and Utilization in Ambulatory Sickle Cell Anemia Patients
12. Early Detection of Responders to Hydroxyurea Therapy: 030
13. Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: Effect of sex, age, and geographical location
14. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
15. Effect of Geography and Climate on Pain Frequency in Patients Enrolled in the Muticenter Study of Hydroxyurea in Sickle Cell Anemia: # 253
16. Age-specific reference ranges for serum prostate-specific antigen in black men
17. Diocesan asset management strategies: the civil law perspective.
18. Predictors of left ventricular function after acute myocardial infarction: Effects of time to treatment, patency, and body mass index: The GUSTO-I angiographic experience
19. Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population
20. Topical paromomycin for New World cutaneous leishmaniasis
21. Epithelial noncarcinoid tumors and tumor-like lesions of the appendix: a clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors
22. Pleomorphic (spindle/giant cell) carcinoma of the lung: a clinicopathologic correlation of 78 cases
23. Prognostic factors in pulmonary fibrohistiocytic lesions
24. Comparison of cardiac findings in patients with mitral valve prolapse who die suddenly to those who have congestive heart failure from mitral regurgitation and to those with fatal noncardiac conditions
25. M.S.A.D. 11 Adult Education for the Handicapped.
26. Multivariate Models for Predicting Progression to AIDS and Survival in Human Immunodeficiency Virus-Infected Persons
27. Racial Differences in Serum β₂-Microglobulin in Persons with Human Immunodeficiency Virus Infection
28. Evaluation of Computer Assisted Telephone Interviewing as a Survey Methodology by Means of Cost Models and Mathematical Programming
29. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
30. Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries
31. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
32. Statement of William F. McCarthy, Ph.D.
33. Evaluation of Computer Assisted Telephone Interviewing as a Survey Methodology by Means of Cost Models and Mathematical Programming
34. Exposure to Hydroxyurea and Pregnancy Outcomes in Patients With Sickle Cell Anemia
35. The Association Between Hydroxyurea Treatment and Pain Intensity, Analgesic Use, and Utilization in Ambulatory Sickle Cell Anemia Patients.
36. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
37. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area
38. Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama
39. Managing Environmental Compliance: A Study of Expansion, Replacement and Integrity Projects
40. Early Detection of Response to Hydroxyurea Therapy in Patients with Sickle Cell Anemia
41. Footprints of Response to Hydroxyurea Are in the Hemogram.
42. Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
43. Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).
44. Definition of the Responder to Hydroxyurea Therapy: Revisited.
45. Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia.
46. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
47. Time Series Analysis of the Pain Diary Data Obtained during the Multicenter Study for Hydroxyurea (MSH) Clinical Trial.
48. Multidetector Computed Tomography Myocardial Perfusion Imaging During Adenosine Stress
49. Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study
50. 858: A Comparison of Two Grading Systems in Predicting Stage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.